About Neuraxis Inc
- Industry: Health Care
- Exchange: NYSE MKT LLC
- Country: US
- Website: https://neuraxis.com/
Frequently Asked Questions
What is the 52-week range for NRXS?
The 52-week high is $9.33 and the 52-week low is $2.21.
What is the P/E ratio for NRXS?
The P/E ratio data is currently unavailable.
What is the dividend yield for NRXS?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is -169.07%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is -144.44%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 14.23.
Analyst Recommendation Trends
Wall Street analyst consensus for NRXS over the last few months:
Latest NRXS News
NeurAxis Positions for Next Phase of Commercial Growth with Appointment of Craig Blanchard as Chief Commercial Officer
CARMEL, Ind., Sept. 29, 2026 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic and debilitating conditions in children and adults, today announced the appointment of Craig Blanchard as Chief Commercial Officer. In this role, Mr. Blanchard will oversee the Company’s commercial functions, including sales and marketing. The appointment of Mr. Blanchard as Chief Commercial Officer
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers DataMEDS AI (NASDAQ:MEDS) shares increased by 354.9% to $7.37 during Wednesday's regular session. The company's market cap stands at $4.9 million. Q/C Technologies (NASDAQ:QCLS) shares increased by
NeurAxis Announces Medical Coverage Policy Milestone, Expanding Access to Over 18 million additional Covered Lives
Total national coverage footprint for PENFS increases to over 120 million covered livesCARMEL, Ind., Sept. 16, 2026 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic and debilitating conditions in children and adults, today announced significant new medical policy coverage from a major national health insurer for Percutaneous Electrical Nerve Field Stimulation (“PENFS”). The c
NeurAxis to Participate in the Lytham Partners Fall 2026 Investor Conference
CARMEL, Ind., Sept. 16, 2026 (GLOBE NEWSWIRE) -- NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic and debilitating conditions in children and adults, will participate in a webcast presentation and host one-on-one meetings with investors at the Lytham Partners Fall 2026 Investor Conference, taking place virtually on September 29-30, 2026. Company Webcast The webcast presentation will take place
Neuraxis Gains Nearly 137% in a Year: What's Driving the Stock?
NRXS is benefiting from stronger IB-Stim volumes, broader reimbursement and VA access, but incomplete payer coverage and cash needs remain challenges.
iAccess Alpha Virtual Best Ideas Fall Investment Conference Begins Today with Updated Presentation Schedule
RALEIGH, NC / ACCESS Newswire / September 15, 2026 / today announced the start of its Virtual Best Ideas Fall Investment Conference, bringing together small and microcap public companies and investors for two days of company presentations and curated one-on-one meetings. The updated presentation schedule appears below.
NeurAxis, Inc. (NRXS) Presents at IAccess Alpha Virtual Best Ideas Fall Investment Conference 2026 Transcript
NeurAxis, Inc. (NRXS) IAccess Alpha Virtual Best Ideas Fall Investment Conference 2026 September 15, 2026 9:00 AM EDTCompany ParticipantsBrian Carrico -...
Is Kodak having a "Kodak moment?" 2 watchlist stocks.
KODK and NRXS are worth watching for their growth.
iAccess Alpha Virtual Best Ideas Fall Investment Conference, September 15-16, 2026
RALEIGH, NC / ACCESS Newswire / September 8, 2026 / today announced that it will host its Virtual Best Ideas Fall Investment Conference on September 15-16, 2026, bringing together small and microcap public companies and investors for two days of company presentations and 1x1 meetings.The conference will begin on Tuesday, September 15, 2026, with a series of live-streamed company presentations.
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-08-24 | Miranda Adrian | -337,204 | - | - |
| 2026-08-24 | Miranda Adrian | +337,204 | - | - |
| 2026-08-24 | Miranda Adrian | -337,204 | $6.94 | $2,340,196 |
| 2026-08-24 | Miranda Adrian | +199,106 | - | - |
| 2026-08-24 | Carrico Thomas Joeseph | -306,236 | - | - |
| 2026-08-24 | Carrico Thomas Joeseph | +306,236 | - | - |
| 2026-08-24 | Carrico Thomas Joeseph | -306,236 | $6.94 | $2,125,278 |
| 2026-08-24 | Carrico Thomas Joeseph | +193,678 | - | - |
| 2026-08-24 | Carrico Brian Allen | -320,000 | - | - |
| 2026-08-24 | Carrico Brian Allen | +320,000 | - | - |
| 2026-08-24 | Carrico Brian Allen | -320,000 | $6.94 | $2,220,800 |
| 2026-08-24 | Carrico Brian Allen | +199,188 | - | - |
| 2026-08-13 | Watkins Bradley Mitchell | +26,073 | $6.28 | $163,738 |
| 2026-08-13 | Miranda Adrian | +133,341 | $6.28 | $837,381 |
| 2026-08-13 | Keyser Jane Elizabeth | +26,073 | $6.28 | $163,738 |
| 2026-08-13 | Henrichs Timothy Robert | +141,479 | $6.28 | $888,488 |
| 2026-08-13 | Carrico Thomas Joeseph | +135,906 | $6.28 | $853,490 |
| 2026-08-13 | Carrico Brian Allen | +193,329 | $6.28 | $1,214,106 |
| 2026-08-13 | Aharon Gil | +43,930 | $6.28 | $275,880 |
| 2026-08-13 | Ferge Kristin A | +31,134 | $6.28 | $195,522 |
| 2026-07-29 | Aharon Gil | +40,068 | - | - |
| 2026-07-29 | Aharon Gil | +2,226 | - | - |
| 2026-04-28 | Aharon Gil | +221,917 | - | - |
| 2026-04-28 | Aharon Gil | +12,304 | - | - |
| 2026-04-01 | Henrichs Timothy Robert | +7,593 | $1.96 | $14,882 |
| 2026-04-01 | Carrico Brian Allen | +8,060 | $1.96 | $15,798 |
| 2026-04-01 | Carrico Thomas Joeseph | +667 | $1.96 | $1,307 |
| 2026-02-12 | Hannasch Brian | +40,000 | $4.92 | $196,800 |
| 2026-02-11 | Hannasch Brian | +40,000 | $4.65 | $186,000 |
| 2026-01-22 | Watkins Bradley Mitchell | +21,598 | $4.63 | $99,999 |
| 2026-01-22 | Keyser Jane Elizabeth | +21,598 | $4.63 | $99,999 |
| 2026-01-22 | Henrichs Timothy Robert | +75,231 | $4.63 | $348,320 |
| 2026-01-22 | Carrico Thomas Joeseph | +47,569 | $4.63 | $220,244 |
| 2026-01-22 | Carrico Brian Allen | +94,173 | $4.63 | $436,021 |
| 2026-01-22 | Miranda Adrian | +47,569 | $4.63 | $220,244 |
| 2026-01-22 | Aharon Gil | +21,598 | $4.63 | $99,999 |
| 2026-01-22 | Ferge Kristin A | +21,598 | $4.63 | $99,999 |
| 2025-12-23 | Aharon Gil | +286,138 | $3.52 | $1,007,206 |